About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Nuklearmedizin - NuclearMedicine
›
top-articles
Nuklearmedizin - NuclearMedicine
0.7
(top 50%)
impact factor
1.2K
(top 20%)
papers
16.7K
(top 10%)
citations
40
(top 20%)
h
-index
1.2
(top 50%)
extended IF
6.0K
all documents
17.2K
doc citations
55
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
High resolution BrainPET combined with simultaneous MRI
Nuklearmedizin - NuclearMedicine
2011
138
2
Automatic volume delineation in oncological PET
Nuklearmedizin - NuclearMedicine
2012
86
3
Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer
Nuklearmedizin - NuclearMedicine
2009
77
4
Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer
Nuklearmedizin - NuclearMedicine
2007
72
5
Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer
Nuklearmedizin - NuclearMedicine
2003
62
6
Brain metastasis in lung cancer
Nuklearmedizin - NuclearMedicine
2011
60
7
Sentinel node mapping in the prostate cancer
Nuklearmedizin - NuclearMedicine
2011
57
8
Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence
Nuklearmedizin - NuclearMedicine
2009
56
9
Integration of FDG- PET/CT into external beam radiation therapy planning
Nuklearmedizin - NuclearMedicine
2012
52
10
Staging in childhood lymphoma: differences between FDG-PET and CT
Nuklearmedizin - NuclearMedicine
2005
52
11
Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19
Nuklearmedizin - NuclearMedicine
2020
50
12
Focal thyroid incidental uptake detected by 18F-fluorodeoxyglucose positron emission tomography
Nuklearmedizin - NuclearMedicine
2013
49
13
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I
Nuklearmedizin - NuclearMedicine
2009
48
14
Cryptate mediated nucleophilic 18F-fluorination without azeotropic drying
Nuklearmedizin - NuclearMedicine
2012
46
15
Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats
Nuklearmedizin - NuclearMedicine
2008
44
16
Two or four hour [18F]FMISO-PET in HNSCC
Nuklearmedizin - NuclearMedicine
2011
44
17
Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI
Nuklearmedizin - NuclearMedicine
2014
41
18
Impact of FDG PET on the management of TBC treatment
Nuklearmedizin - NuclearMedicine
2010
41
19
Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma
Nuklearmedizin - NuclearMedicine
2009
40
20
Incidental uptake of 18F-fluorodeoxyglucose in the prostate gland
Nuklearmedizin - NuclearMedicine
2014
39
21
Combination of MRI and dynamic FET PET for initial glioma grading
Nuklearmedizin - NuclearMedicine
2014
38
22
Percutaneous thermal microwave ablation of thyroid nodules
Nuklearmedizin - NuclearMedicine
2014
36
23
Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging
Nuklearmedizin - NuclearMedicine
2008
35
24
Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression
Nuklearmedizin - NuclearMedicine
2004
34
25
MIBI scintigraphy in hypofunctioning thyroid nodules
Nuklearmedizin - NuclearMedicine
2009
33
26
Risk stratification of patients with locally aggressive differentiated thyroid cancer
Nuklearmedizin - NuclearMedicine
2010
33
27
Prolonged back pain attributed to suspected spondylodiscitis
Nuklearmedizin - NuclearMedicine
2012
32
28
Can peptide receptor radionuclide therapy be safely applied in florid bone metastases?
Nuklearmedizin - NuclearMedicine
2014
31
29
Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines
Nuklearmedizin - NuclearMedicine
2014
31
30
Preoperative risk stratification using 18F-FDG PET/CT in women with endometrial cancer
Nuklearmedizin - NuclearMedicine
2011
30
31
Influence of PET reconstruction para meters on the TrueX algorithm
Nuklearmedizin - NuclearMedicine
2013
30
32
Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy
Nuklearmedizin - NuclearMedicine
2018
30
33
Value of combined XCT/SPECT technology for avoiding false positive planar 123I-MIBG scintigraphy
Nuklearmedizin - NuclearMedicine
2004
30
34
124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact
Nuklearmedizin - NuclearMedicine
2007
30
35
Distant metastatic lesions in patients with differentiated thyroid carcinoma
Nuklearmedizin - NuclearMedicine
2013
29
36
Real-time ultrasound and freehand-SPECT
Nuklearmedizin - NuclearMedicine
2014
29
37
Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization
Nuklearmedizin - NuclearMedicine
2014
28
38
CME-Fragebogen
Nuklearmedizin - NuclearMedicine
2008
27
39
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP
Nuklearmedizin - NuclearMedicine
2016
27
40
Combination of ultrasound guided percutaneous microwave ablation and radioiodine therapy in benign thyroid diseases
Nuklearmedizin - NuclearMedicine
2015
26
41
Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma
Nuklearmedizin - NuclearMedicine
2017
26
42
Multi-centre calibration of an adaptive thresholding method for PET-based delineation of tumour volumes in radiotherapy planning of lung cancer
Nuklearmedizin - NuclearMedicine
2012
25
43
Percutaneous microwave ablation of benign thyroid nodules
Nuklearmedizin - NuclearMedicine
2015
25
44
FDG uptake in primary squamous cell carcinoma of the head and neck
Nuklearmedizin - NuclearMedicine
2011
24
45
Global scaling for semi-quantitative analysis in FP-CIT SPECT
Nuklearmedizin - NuclearMedicine
2014
24
46
Reference range for thyrotropin
Nuklearmedizin - NuclearMedicine
2015
24
47
99mTc-labeled ubiquicidin scintigraphy
Nuklearmedizin - NuclearMedicine
2012
23
48
MRI versus bone scintigraphy
Nuklearmedizin - NuclearMedicine
2012
23
49
FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review
Nuklearmedizin - NuclearMedicine
2009
23
50
18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma
Nuklearmedizin - NuclearMedicine
2013
22
site/software ©
exaly
; All materials licenced under
CC by-SA
.